BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34115714)

  • 21. Bone marrow enhances the performance of rhBMP-2 in spinal fusion: a rodent model.
    Bae HW; Zhao L; Kanim LE; Wong P; Marshall D; Delamarter RB
    J Bone Joint Surg Am; 2013 Feb; 95(4):338-47. PubMed ID: 23426768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis.
    Singh K; Dumonski M; Stanley T; Ponnappan R; Phillips FM
    Spine (Phila Pa 1976); 2011 Feb; 36(3):192-6. PubMed ID: 20634780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of vancomycin powder on bone healing in a rat spinal rhBMP-2 model.
    Mendoza MC; Sonn KA; Kannan AS; Bellary SS; Mitchell SM; Singh G; Park C; Yun C; Stock SR; Hsu EL; Hsu WK
    J Neurosurg Spine; 2016 Aug; 25(2):147-53. PubMed ID: 27035510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy comparison of Accell Evo3 and Grafton demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model.
    Brecevich AT; Kiely PD; Yoon BV; Nguyen JT; Cammisa FP; Abjornson C
    Spine J; 2017 Jun; 17(6):855-862. PubMed ID: 28126356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
    Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
    Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a new formulation of demineralized bone matrix putty in a rabbit posterolateral spinal fusion model.
    Kiely PD; Brecevich AT; Taher F; Nguyen JT; Cammisa FP; Abjornson C
    Spine J; 2014 Sep; 14(9):2155-63. PubMed ID: 24512696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of DBM/AM composite as a graft substitute for posterolateral lumbar fusion.
    Qiu QQ; Shih MS; Stock K; Panzitta T; Murphy PA; Roesch SC; Connor J
    J Biomed Mater Res B Appl Biomater; 2007 Jul; 82(1):239-45. PubMed ID: 17183565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
    Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion.
    Mulconrey DS; Bridwell KH; Flynn J; Cronen GA; Rose PS
    Spine (Phila Pa 1976); 2008 Sep; 33(20):2153-9. PubMed ID: 18725869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An effective delivery vehicle of demineralized bone matrix incorporated with engineered collagen-binding human bone morphogenetic protein-2 to accelerate spinal fusion at low dose.
    Zhu W; Qiu Y; Sheng F; Yuan X; Xu L; Bao H; Dai J; Zhu Z
    J Mater Sci Mater Med; 2017 Dec; 29(1):2. PubMed ID: 29196819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial.
    Choi JY; Park HJ; Park SM; Kang CN; Song KS
    J Orthop Surg Res; 2022 Aug; 17(1):397. PubMed ID: 36045371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
    Park DK; Kim SS; Thakur N; Boden SD
    Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
    Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
    Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion.
    Minamide A; Yoshida M; Kawakami M; Yamasaki S; Kojima H; Hashizume H; Boden SD
    Spine (Phila Pa 1976); 2005 May; 30(10):1134-8. PubMed ID: 15897826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
    Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
    Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis.
    Martin GJ; Boden SD; Titus L; Scarborough NL
    Spine (Phila Pa 1976); 1999 Apr; 24(7):637-45. PubMed ID: 10209791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.